Literature DB >> 14693181

PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer.

Aydan Eroğlu, Ragip Cam, Züleyha Yildiz, Nejat Akar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14693181     DOI： 10.1016/j.thromres.2003.09.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  1 in total

1.  Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.

Authors:  Aydan Eroglu; Arzu Ulu; Ragip Cam; Cengiz Kurtman; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.